NYMC Faculty Publications
Intracranial Hemorrhage in Patient Treated With Rivaroxaban
Author Type(s)
Faculty
DOI
10.4081/hr.2014.5283
Journal Title
Hematology Reports
First Page
5283
Last Page
5283
Document Type
Article
Publication Date
1-29-2014
Department
Neurology
Disciplines
Medicine and Health Sciences
Abstract
Rivaroxaban is an oral factor Xa inhibitor used for stroke prevention in atrial fibrillation. There are currently no evidence-based guidelines for the treatment of hemorrhagic side effects of factor Xa inhibitors. We report a case of a thalamic hemorrhage in an 84 year-old right-handed female on rivaroxaban for treatment of atrial fibrillation. The patient had fallen down steps and became unresponsive. She was found to have diffuse scattered acute subarachnoid hemorrhage as well as intraventricular hemorrhage. Neurosurgical intervention was not required in this case, but controversy over decision making to pursue pro-coagulant therapy in the setting of worsening hemorrhage requiring emergent surgery is discussed.
Recommended Citation
Molina, M., Hillard, V. H., & Fekete, R. (2014). Intracranial Hemorrhage in Patient Treated With Rivaroxaban. Hematology Reports, 6 (1), 5283-5283. https://doi.org/10.4081/hr.2014.5283
